{"title":"喀麦隆巴门达地区医院糖尿病患者丙型肝炎病毒感染发生率及潜在预测因素","authors":"Lem Edith Abongwa, Ntoh Bazil Kuh, Kubong Rene Ndenge","doi":"10.47363/jghr/2022(3)130","DOIUrl":null,"url":null,"abstract":"Introduction: Diabetes mellitus (DM) and Hepatitis C Virus (HCV) infections are a global major public health threat. Their co-infections and associated risk factors have been postulated in many countries, unfortunately, no such data exist in Cameroon. This study aims to determine the prevalence and possible predictors of HCV among DM patients. Methods: We conducted a cross-sectional study among DM patients at Regional Hospital Bamenda from February to June 2020. Blood samples were collected and tested for the presence of HCV. Data were analyzed using SPSS version 23. Results: The study comprised 193 participants. The mean (Std. error) age and random blood sugar level of the participants were 46.12(0.9) years and 134.15(4.07) g/dl respectively. HCV prevalence was 3.11% (6). The distribution of HCV infection did not show any significant difference with social demographic factors (p > 0.05). Similarly, HCV was insignificantly (p > 0.05) higher in patients with T2DM 6(3.4%), those with disease duration >5 years 4(4.4%), and those receiving injectable drugs 2(9.1%). Possible predictors (p<0.05) of HCV identified in this study include; uncontrolled diabetes (7.4%), family history of diabetes (19.2%), hepatitis 2(15.4%), alcohol intake (7.6%), multiple sex partners (6.5%), sharing sharp objects (9.1%), those with Tattoos (9.4%), scarification marks (3.6%), as well as those who have been hospitalized (6.7%), or received blood transfusion (25.0%) at least once. Conclusion: HCV testing and linkage to care among DM patients should be made imperative in order to design effective treatment and prevention programs that will reduce the morbidity and mortality rates.","PeriodicalId":363979,"journal":{"name":"Journal of Gastroenterology & Hepatology Reports","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Incidence of Hepatitis C Virus infection and the potential predictors among patients with diabetes mellitus in the Bamenda Regional Hospital in Cameroon\",\"authors\":\"Lem Edith Abongwa, Ntoh Bazil Kuh, Kubong Rene Ndenge\",\"doi\":\"10.47363/jghr/2022(3)130\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Diabetes mellitus (DM) and Hepatitis C Virus (HCV) infections are a global major public health threat. Their co-infections and associated risk factors have been postulated in many countries, unfortunately, no such data exist in Cameroon. This study aims to determine the prevalence and possible predictors of HCV among DM patients. Methods: We conducted a cross-sectional study among DM patients at Regional Hospital Bamenda from February to June 2020. Blood samples were collected and tested for the presence of HCV. Data were analyzed using SPSS version 23. Results: The study comprised 193 participants. The mean (Std. error) age and random blood sugar level of the participants were 46.12(0.9) years and 134.15(4.07) g/dl respectively. HCV prevalence was 3.11% (6). The distribution of HCV infection did not show any significant difference with social demographic factors (p > 0.05). Similarly, HCV was insignificantly (p > 0.05) higher in patients with T2DM 6(3.4%), those with disease duration >5 years 4(4.4%), and those receiving injectable drugs 2(9.1%). Possible predictors (p<0.05) of HCV identified in this study include; uncontrolled diabetes (7.4%), family history of diabetes (19.2%), hepatitis 2(15.4%), alcohol intake (7.6%), multiple sex partners (6.5%), sharing sharp objects (9.1%), those with Tattoos (9.4%), scarification marks (3.6%), as well as those who have been hospitalized (6.7%), or received blood transfusion (25.0%) at least once. Conclusion: HCV testing and linkage to care among DM patients should be made imperative in order to design effective treatment and prevention programs that will reduce the morbidity and mortality rates.\",\"PeriodicalId\":363979,\"journal\":{\"name\":\"Journal of Gastroenterology & Hepatology Reports\",\"volume\":\"5 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Gastroenterology & Hepatology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jghr/2022(3)130\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gastroenterology & Hepatology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jghr/2022(3)130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
糖尿病(DM)和丙型肝炎病毒(HCV)感染是全球主要的公共卫生威胁。他们的共同感染和相关的危险因素在许多国家都是假定的,不幸的是,喀麦隆没有这样的数据。本研究旨在确定糖尿病患者中HCV的患病率和可能的预测因素。方法:我们于2020年2月至6月在巴门达地区医院对糖尿病患者进行了横断面研究。采集血样并检测丙型肝炎病毒的存在。数据分析采用SPSS version 23。结果:该研究包括193名参与者。参与者的平均(标准差)年龄和随机血糖水平分别为46.12(0.9)岁和134.15(4.07)g/dl。HCV患病率为3.11%(6)。HCV感染分布与社会人口统计学因素差异无统计学意义(p > 0.05)。同样,2型糖尿病患者(3.4%)、病程>5年4(4.4%)和接受注射药物2(9.1%)的HCV升高无统计学意义(p > 0.05)。本研究确定的HCV可能的预测因素(p<0.05)包括;未控制的糖尿病(7.4%),糖尿病家族史(19.2%),2型肝炎(15.4%),酒精摄入(7.6%),多个性伴侣(6.5%),共用尖锐物品(9.1%),有纹身(9.4%),划痕(3.6%),以及住院(6.7%)或至少接受过一次输血(25.0%)的人。结论:为了设计有效的治疗和预防方案,降低发病率和死亡率,应在糖尿病患者中进行HCV检测并与护理联系起来。
Incidence of Hepatitis C Virus infection and the potential predictors among patients with diabetes mellitus in the Bamenda Regional Hospital in Cameroon
Introduction: Diabetes mellitus (DM) and Hepatitis C Virus (HCV) infections are a global major public health threat. Their co-infections and associated risk factors have been postulated in many countries, unfortunately, no such data exist in Cameroon. This study aims to determine the prevalence and possible predictors of HCV among DM patients. Methods: We conducted a cross-sectional study among DM patients at Regional Hospital Bamenda from February to June 2020. Blood samples were collected and tested for the presence of HCV. Data were analyzed using SPSS version 23. Results: The study comprised 193 participants. The mean (Std. error) age and random blood sugar level of the participants were 46.12(0.9) years and 134.15(4.07) g/dl respectively. HCV prevalence was 3.11% (6). The distribution of HCV infection did not show any significant difference with social demographic factors (p > 0.05). Similarly, HCV was insignificantly (p > 0.05) higher in patients with T2DM 6(3.4%), those with disease duration >5 years 4(4.4%), and those receiving injectable drugs 2(9.1%). Possible predictors (p<0.05) of HCV identified in this study include; uncontrolled diabetes (7.4%), family history of diabetes (19.2%), hepatitis 2(15.4%), alcohol intake (7.6%), multiple sex partners (6.5%), sharing sharp objects (9.1%), those with Tattoos (9.4%), scarification marks (3.6%), as well as those who have been hospitalized (6.7%), or received blood transfusion (25.0%) at least once. Conclusion: HCV testing and linkage to care among DM patients should be made imperative in order to design effective treatment and prevention programs that will reduce the morbidity and mortality rates.